Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score.
Cançado GGL, Gomes NMF, Couto CA, Cançado ELR, Terrabuio DRB, Villela-Nogueira CA, Braga MH, Nardelli MJ, Faria LC, Oliveira EMG, Rotman V, Oliveira MB, Cunha SMCFD, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, Borges VFAE, Pace FHL, Pessôa MG, Signorelli IV, Coral GP, Bittencourt PL, Fucuta P, Filho RJC, Ferraz MLG. Cançado GGL, et al. Among authors: ferraz mlg. Eur J Gastroenterol Hepatol. 2024 May 1;36(5):628-635. doi: 10.1097/MEG.0000000000002744. Epub 2024 Mar 25. Eur J Gastroenterol Hepatol. 2024. PMID: 38555601
Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis.
Gallo CA, Dellavance A, Gama RA, Silva AE, Silva ISSE, Andrade LEC, Ferraz MLG. Gallo CA, et al. Among authors: ferraz mlg. Einstein (Sao Paulo). 2023 Nov 17;21:eAO0375. doi: 10.31744/einstein_journal/2023AO0375. eCollection 2023. Einstein (Sao Paulo). 2023. PMID: 37991088 Free PMC article.
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH, Cançado GGL, Bittencourt PL, Couto CA, Guedes LV, Lima AMC, Ferraz MLG, Villela-Nogueira CA, Nardelli MJ, Faria LC, Gomes NMF, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Filho JG, Chagas AL, Terrabuio DRB, Cançado ELR; Members of the Brazilian Cholestasis Study Group Consortium. Braga MH, et al. Among authors: ferraz mlg. Ann Hepatol. 2023 Jul-Aug;28(4):101105. doi: 10.1016/j.aohep.2023.101105. Epub 2023 Apr 23. Ann Hepatol. 2023. PMID: 37088418 Free article.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
Razavi HA, Buti M, Terrault NA, Zeuzem S, Yurdaydin C, Tanaka J, Aghemo A, Akarca US, Al Masri NM, Alalwan AM, Aleman S, Alghamdi AS, Alghamdi S, Al-Hamoudi WK, Aljumah AA, Altraif IH, Asselah T, Ben-Ari Z, Berg T, Biondi MJ, Blach S, Braga WSM, Brandão-Mello CE, Brunetto MR, Cabezas J, Cheinquer H, Chen PJ, Cheon ME, Chuang WL, Coffin CS, Coppola N, Craxi A, Crespo J, De Ledinghen V, Duberg AS, Etzion O, Ferraz MLG, Ferreira PRA, Forns X, Foster GR, Gaeta GB, Gamkrelidze I, García-Samaniego J, Gheorghe LS, Gholam PM, Gish RG, Glenn J, Hercun J, Hsu YC, Hu CC, Huang JF, Janjua N, Jia J, Kåberg M, Kaita KDE, Kamal H, Kao JH, Kondili LA, Lagging M, Lázaro P, Lazarus JV, Lee MH, Lim YS, Marotta PJ, Navas MC, Naveira MCM, Orrego M, Osiowy C, Pan CQ, Pessoa MG, Raimondo G, Ramji A, Razavi-Shearer DM, Razavi-Shearer K, Ríos-Hincapié CY, Rodríguez M, Rosenberg WMC, Roulot DM, Ryder SD, Safadi R, Sanai FM, Santantonio TA, Sarrazin C, Shouval D, Tacke F, Tergast TL, Villalobos-Salcedo JM, Voeller AS, Yang HI, Yu ML, Zuckerman E; Polaris Observatory. Razavi HA, et al. Among authors: ferraz mlg. J Hepatol. 2023 Aug;79(2):576-580. doi: 10.1016/j.jhep.2023.02.041. Epub 2023 Apr 6. J Hepatol. 2023. PMID: 37030400 Free article.
Poor linkage to care may compromise the Brazilian plan for hepatitis C elimination.
Bittencourt PL, do Socorro Ferreira Iasi M, Viana MV, Crespo DM, Emerim E, de Almeida Borges PS, de Andrade ARC, Codes L, Ferraz MLG. Bittencourt PL, et al. Among authors: ferraz mlg. J Viral Hepat. 2023 Feb;30(2):176-178. doi: 10.1111/jvh.13762. Epub 2022 Nov 26. J Viral Hepat. 2023. PMID: 36302169 No abstract available.
Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver.
Villela-Nogueira CA, Ferraz MLG, Pessoa MG, Souto FJD, Nabuco LC, Coelho HSM, Ridruejo E, Silva M, Bittencourt PL, Brandão-Mello CE; Members of the Brazilian Society of Hepatology. Villela-Nogueira CA, et al. Among authors: ferraz mlg. Ann Hepatol. 2023 Jan-Feb;28(1):100764. doi: 10.1016/j.aohep.2022.100764. Epub 2022 Sep 28. Ann Hepatol. 2023. PMID: 36182033 Free article.
99 results